Informed Decline: Remdesivir
On April 25, the FDA extended its approval of Gilead’s drug Remdesivir (aka Veklury) to include children as young as 28 days old. Gilead’s controversial drug has a history that even mainstream science and news sources have questioned. According to the journal Science regarding the initial approval in October 2020 : . . . both FDA’s
Informed Decline: Remdesivir Read More »



